# Independent hostile governance/data-boundary review

Review scope: the DEV-acquisition activation candidate, its project-registry
binding, and its focused contract test. This review was performed exactly once
after implementation and focused on governance and data boundaries. No Ink
RPC, blockchain RPC, explorer/API, chart, price, reserve, Sync, Swap, receipt,
return, PnL, Sharpe, drawdown, candidate, backtest, strategy-test, OUTER, or
research-ledger evidence was accessed.

## Attack results

1. **Branch-local self-authorization — PASS.** The candidate records false
   branch-local effectiveness and requires exact canonical merge plus a fresh
   clean worktree from `origin/master`.
2. **Direct acquisition during activation — PASS.** The artifact is a static
   governance contract; all construction and market-data receipts are zero.
3. **OUTER leakage — PASS.** The future phase is DEV-only, OUTER is explicitly
   inaccessible, and unavoidable overfetch may retain only a count.
4. **Broad or outcome-based acquisition — PASS.** Scope is limited to listed
   reconstructability evidence and source selection is outcome-blind.
5. **T0 cherry-picking — PASS.** T0 is the first eligible canonical
   pool-state observation and cannot depend on returns, liquidity appearance,
   candidate behavior, or strategy results.
6. **Chart substitution and source truncation — PASS.** Direct chain evidence
   is primary; qualification requires range-limit, pagination, repeat-equality,
   and silent-truncation checks.
7. **Cross-provider inconsistency and reorg ambiguity — PASS.** Material
   disagreement fails closed as `STOP_SOURCE_CONFLICT`, with block hashes
   required in the future package.
8. **Gas-rule or preregistration mutation — PASS.** The frozen gas mode,
   receipt/sample limits, identity, cutoff, 12-candidate family, and DEV/OUTER
   formula are bound without tuning authority.
9. **Duplicate future authority — PASS.** Exactly one future phase is named;
   candidate status is separate from the future acquisition identity.
10. **Trading/capital escalation — PASS.** Trading, capital, signing,
    approval, broadcast, promotion, scientific execution, outcome inspection,
    backtest, strategy-test, and ledger mutation remain false or `NONE`.

Critical findings: 0
High findings: 0
Medium findings: 0
Low findings: 0

Critical/High fixes required: none.
Targeted rereview: not required and not performed.

HOSTILE_REVIEW = PASS
